National Association for Continence

Axena Health welcomes 4 distributors for the Leva Pelvic Health System

Retrieved on: 
Tuesday, January 9, 2024
Women, Seniors, General Health, Health, Medical Devices, Consumer, Clinical Trials, Other Health, Woman, Patient, NAFC, Continence, Female, Fecal incontinence, PFMT, Urinary incontinence, Embarrassment, Kegel exercise, Quality of life, Incontinence, Accidental, National Association for Continence, UI, FDA, Doctor of Philosophy, Shame, Pelvic floor, Physician

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, has signed agreements with four leading distributors to streamline access to the Leva® Pelvic Health System.

Key Points: 
  • Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, has signed agreements with four leading distributors to streamline access to the Leva® Pelvic Health System.
  • While UI and FI are the most prevalent pelvic floor disorders among women, they are vastly undertreated.
  • The Leva System makes PFMT accessible by supporting a women’s success as she improves her incontinence symptoms.
  • "Pelvic floor muscle training is a globally recommended solution that Leva makes more accessible to women.

American Urological Association Names New Treasurer-Elect

Retrieved on: 
Thursday, November 2, 2023
National Association, MIT, AUA, Urology, American Urological Association, MD, Organization, Nativ College Leadership Program, Leadership Institute, Executive Committee, Business, Continence, National Association for Continence, Accounting, Massachusetts Institute of Technology, Treasurer, Management

BALTIMORE, Nov. 2, 2023 /PRNewswire/ -- The American Urological Association (AUA) is pleased to announce Jennifer Miles-Thomas, MD, has been named Treasurer-elect, a position she will assume in May 2024 with ratification at the AUA Annual Business Meeting, and hold until May 2025 when she will become Treasurer of the Association for a four-year term.

Key Points: 
  • BALTIMORE, Nov. 2, 2023 /PRNewswire/ -- The American Urological Association (AUA) is pleased to announce Jennifer Miles-Thomas, MD, has been named Treasurer-elect, a position she will assume in May 2024 with ratification at the AUA Annual Business Meeting, and hold until May 2025 when she will become Treasurer of the Association for a four-year term.
  • As the Treasurer-elect, Dr. Miles-Thomas will have the vital role of ensuring the financial security of both the AUA and Urology Care Foundation.
  • This includes overseeing financial reporting and compliance with both Boards of Directors and various stakeholders, including AUA members.
  • She is currently the President and CEO of Urology of Virginia, is a board member of the Schellhammer Urological Research Foundation, American Association of Clinical Urologists, as well as the National Association for Continence, and holds various leadership positions with other organizations.

BlueWind Medical Announces New Executive Appointments

Retrieved on: 
Tuesday, November 1, 2022
Athlone Institute of Technology, Continence, Dundalk Institute of Technology, OASIS, Biomedical engineering, Industry, Respiratory disease, FDA, AbbVie, Man, Urinary incontinence, Regenerative medicine, Urine, Development, CEO, Medtech, Master of Business Administration, Research and development, Allergan, University, Bachelor of Engineering, Burden, Patient, Artificial intelligence, Overactive bladder, Multimedia, TE Connectivity, Food and Drug Administration, University Hospital Galway, National Association, Woman, Medtronic, National Association for Continence, IDE, Leadership, Business administration, OAB, Public health, Varicose veins, Boston Scientific, Food, Ankle, WS, PARK, Management, Medical device, Operation, Tel Aviv University, Quality, Research, Engineering, Technology

PARK CITY, Utah and HERZLIYA, Israel, Nov. 1, 2022 /PRNewswire/ --BlueWind Medical, Ltd., a medical device company transforming neuromodulation therapy for overactive bladder (OAB), announced three executive appointments to leadership positions within the company.

Key Points: 
  • PARK CITY, Utah and HERZLIYA, Israel, Nov. 1, 2022 /PRNewswire/ --BlueWind Medical, Ltd., a medical device company transforming neuromodulation therapy for overactive bladder (OAB), announced three executive appointments to leadership positions within the company.
  • "This group of talented professionals bring mature and multinational company experience," said Dan Lemaitre, Chairman and CEO of BlueWind Medical.
  • Seamus O'Connor brings 23 years of experience in the medical device industry across quality assurance and regulatory affairs, working with various medical device technologies.
  • Prior to BlueWind Medical, Seamus held positions of increasing responsibility at MEDNOVA, TE Connectivity, Boston Scientific and Natus Medical.

BlueWind Medical Appoints Dr. Liz Kwo to Board of Directors

Retrieved on: 
Tuesday, September 27, 2022
MPH, Overactive bladder, OASIS, Burden, Woman, FDA, IDE, Knowledge, OAB, National Association for Continence, Continence, Cambridge Health Alliance, Patient, Commercial software, Automation, CEO, MBA, Quality of life, Population health, WS, Solution, Board of directors, Occupational medicine, Ankle, Artificial intelligence, Harvard Medical School, Board, Data science, Urine, National Association, Multimedia, Man, PARK, Public health, Medicine, Medical device

PARK CITY, Utahand HERZLIYA,Israel, Sept.27, 2022 /PRNewswire/ -- BlueWind Medical, Ltd., a medical device company working to transform neuromodulation therapy for overactive bladder (OAB), announced today that Liz Kwo, M.D., MBA, MPH, Chief Medical Officer at Everly Health, has joined the company's Board of Directors.

Key Points: 
  • PARK CITY, Utahand HERZLIYA,Israel, Sept.27, 2022 /PRNewswire/ -- BlueWind Medical, Ltd., a medical device company working to transform neuromodulation therapy for overactive bladder (OAB), announced today that Liz Kwo, M.D., MBA, MPH, Chief Medical Officer at Everly Health, has joined the company's Board of Directors.
  • "I am pleased to join BlueWind Medical at this exciting phase and supportthe company's mission to revolutionize neuromodulation therapy for overactive bladder."
  • "Dr. Kwo is a distinguished physician, leader, and entrepreneur with extensive knowledge in building and scaling healthcare products to improve outcomes and quality care," said Dan Lemaitre, Chairman and CEO of BlueWind Medical.
  • BlueWind Medical is an innovative medical device company that is transforming neuromodulation therapy for the treatment of Overactive Bladder (OAB).

Prestigious journal shows leva Pelvic Health System significantly improves urinary incontinence symptoms in women

Retrieved on: 
Monday, March 14, 2022
National Association for Continence, Urinary incontinence, Obstetrics, Sexual dysfunction, Woman, Hope, American College of Obstetricians and Gynecologists, Education, Quality of life, RCT, American College, UI, Physician, PFMT, MD, Continence, Health, National Association, Food and Drug Administration, Prevalence, Incontinence, Doctor of Philosophy, Rehabilitation, Pelvic floor, Overactive bladder, Obstetrics and gynaecology, Kegel exercise, Digital, Technology, NAFC, Paruresis, All rights reserved, Program, Food, Association, Diagnosis, Use, ACOG, Randomized controlled trial, Dietary supplement, Pharmaceutical industry, Medical device, Gynaecology, Gynaecology

CHARLESTON, S.C., March 14, 2022 /PRNewswire/ -- The National Association for Continence (NAFC), the nation's leading advocate for people living with bladder and bowel disorders, highlighted a new study today that offers hope for the 78 million women who experience urinary incontinence (UI). On March 10, the official journal of the American College of Obstetricians and Gynecologists (ACOG), Obstetrics & Gynecology ("the green journal") published a rigorous study showing that women with UI who performed pelvic floor muscle training (PFMT) using leva achieved significant improvement in their UI symptoms and fewer leaks compared with women who followed a program of Kegel exercises alone.

Key Points: 
  • "The green journal is among the most prestigious journals in women's health," said Steven G. Gregg, PhD, Executive Director of NAFC.
  • "Women have been looking for a good, effective treatment for stress urinary incontinence for years.
  • The levaPelvic Health Systemcombines novel motion sensor technology with a smartphone app and personal coaching, which helps women perform PFMT successfully.
  • The leva Pelvic Health System, developed by Renovia Inc., is intended for strengthening of pelvic floor muscles, and rehabilitation and training of weak pelvic floor muscles for the treatment of stress, mixed, and mild to moderate urgency urinary incontinence (including overactive bladder) in women.

Renovia receives Breakthrough Device Designation for leva® Digital Therapeutic as first-line treatment for chronic fecal incontinence

Retrieved on: 
Friday, October 29, 2021
Woman, Digital, Depression, Rehabilitation, Storey, National Association for Continence, Urinary incontinence, Fecal incontinence, FDA, Food, Risk, NAFC, Freedom, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Smartphone, FI, Social isolation, All rights reserved, Pelvic floor, Ageing, Use, Privacy, Distress, Female, UI, Therapy, Guilt, Population, Sexual dysfunction, Prevalence, Overactive bladder, Shame, Physician, Pharmaceutical industry, Medicine, Birth control

BOSTON, Oct. 29, 2021 /PRNewswire/ -- Renovia Inc. ("Renovia"), a women-led company that develops digital therapeutics for female pelvic floor disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the leva® Digital Therapeutic System as a first-line treatment for chronic fecal incontinence (FI) in women. The leva Digital Therapeutic is currently FDA-cleared for the treatment of urinary incontinence (UI) and pelvic floor strengthening in women. 

Key Points: 
  • The leva Digital Therapeutic is currently FDA-cleared for the treatment of urinary incontinence (UI) and pelvic floor strengthening in women.
  • "While the leva Digital Therapeutic is not yet FDA cleared for the treatment of fecal incontinence, we are hopeful that Breakthrough Device Designation will help expedite patient access to the leva System as a first-line treatment for a profoundly debilitating condition."
  • Fecal incontinence, commonly referred to as accidental bowel leakage, is a debilitating and progressive condition affecting 12 million U.S. women.
  • Stephen Gregg, Executive Director of the National Association For Continence (NAFC) offered, "Women with chronic fecal incontinence have few treatment options beyond drugs or surgery.

NAFC names Renovia, developer of the leva® Pelvic Health System, as Trusted Partner

Retrieved on: 
Tuesday, October 12, 2021
DTA, Twitter, UI, Sexual dysfunction, American College of Obstetricians and Gynecologists, PFD allowance, Continence, National Association, Urinary incontinence, Physician, NAFC, Use, LinkedIn, Female, Overactive bladder, Industry, Diagnosis, All rights reserved, FDA, Instagram, Health, Prevalence, Quality of life, Woman, Incontinence, Storey, Rehabilitation, ACOG, Trusted Partner, CEO, Learning, Therapy, Partner, Association, Gynaecology, Patient, Pelvic floor, Human, American College, Women's health, National Association for Continence, Organization, Paruresis, Pharmaceutical industry, Medical device, Birth control

"NAFC has long been an advocate for improving pelvic health," said Steve Gregg, executive director of the non-profit NAFC.

Key Points: 
  • "NAFC has long been an advocate for improving pelvic health," said Steve Gregg, executive director of the non-profit NAFC.
  • PFD Week offers an additional and much-needed reminder of how important pelvic floor health is to preventing incontinence.
  • The leva Pelvic Health System offers a novel, non-invasive, medication-free way for women to train and strengthen their pelvic floor musclesat home in just five minutes a dayto treat urinary incontinence (UI).
  • For more information about Renovia or the leva Pelvic Health System please visit www.renoviainc.com or follow the company on Twitter , Facebook , LinkedIn and Instagram .